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Abstract
Introduction. Many patients of all ages are admitted to hospital due to bone fractures. The etiology of fracture 
has a very wide spectrum, ranging from motor accidents to pathological conditions such as tumors, osteoporosis, 
and others. Bone fracture healing is a well-programmed and well-organized process, but is also long and in-
tractable. The outcome of this process is therefore affected by many factors, such as the patient’s age, ethnicity, 
nutritional status, and extent of the fracture. At present, regional analgesic techniques are frequently applied 
in order to avoid the complications of systemic opioid administration, central block applications. Femoral block 
is one of the regional analgesic techniques frequently applied by anesthesiologists when the lower extremities 
are involved. In this study, we evaluated the effect of femoral nerve block on the healing of an experimental 
non-stabilized femur fracture via expression of TGF-b, VEGF, and b-catenin and bone histomorphometry in rats. 
Material and methods. In the control group, only the femoral fracture was performed and the bone was not 
fixated, similarly as in other groups. In the One-Day Block group, a one-time femoral nerve block was applied 
after the femoral fracture. In the Three-Day Block group, a daily femoral nerve block was performed for three 
days after the femoral fracture. On Days 4, 7, and 13, femurs were excised. The bone sections were stained with 
hematoxylin-eosin to evaluate bone tissue and Safranin O to assess callus tissue, cartilaginous tissue, and new 
bone areas. TGF-b, VEGF, and b-catenin were assessed by immunohistochemistry.
Results. Histomorphometric analysis revealed that femoral block application had a positive impact on bone 
healing. TGF-b expression in the One-Day and Three-Day Block Groups was significantly higher than in the 
control group at all times, as was also the case with VEGF expression. On day 13, b-catenin expression was 
significantly higher in the Three-Day Block group than the others. 
Conclusions. The results of the study suggests that the applications of a femoral nerve block for perioperative 
analgesia, for either one day or three days, resulted in better and more rapid bone healing. (Folia Histochemica 
et Cytobiologica 2016, Vol. 54, No. 3, 151–158)
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Introduction
Patients of all ages are admitted to hospital due to bone 
fractures in great numbers. The etiology of fracture 
covers a very wide spectrum, from motor accidents to 
pathological conditions such as tumors, osteoporosis, 
and so on. Bone fracture healing is a well-programmed 
and well-organized process, but it is also long and 
intractable. The outcome of the process is thus affect-
ed by many factors, such as patient’s age, ethnicity, 
nutritional status, physical condition, and the etiology 
and extent of the fracture [1–5]. The healing process 
following bone fracture takes one of two different 
paths, depending on whether or not a stabilization 
procedure was performed: non-stabilized fractures heal 
via endochondral ossification, while stabilized fractures 
heal via intramembranous ossification [6]. The process 
of endochondral ossification begins with the prolifera-
tion and differentiation of mesenchymal cells (MSCs) 
into cartilage in the following six stages: hematoma 
formation and inflammation, angiogenesis, formation 
of cartilage, calcification of cartilage, cartilaginous 
transformation into bone, and remodeling [1, 7].
Many key regulating factors and signaling path-
ways affect bone repair; these include fibroblast 
growth factors (FGFs), platelet-derived growth factors 
(PDGFs), transforming growth factor beta (TGF-b), 
vascular endothelial growth factors (VEGFs), and 
bone morphogenetic proteins (BMPs) [4, 5]. TGF-b 
has direct effects on the regulation of osteoblast 
differentiation; its reduction in osteoblasts has been 
shown to expand bone mineral concentration and 
bone mass [8–10]. VEGF, a known promoter of angio-
genesis, stimulates neovascularization and promotes 
fracture healing, and also regulates activity of osteo-
clasts and osteoblasts [11, 12]. The formation of new 
blood vessels (angiogenesis) plays an important role 
during bone fracture healing since vascular changes 
precede bone formation [13]. b-catenin is essential 
in determining whether MSC progenitors become 
osteoblasts and suppress osteoclasts [4, 14, 15].
Nowadays, regional analgesic techniques are fre-
quently applied in order to avoid the complications 
of systemic opioid administration, central block 
applications, to supply better perioperative analgesia 
and reduce costs and duration of hospitalization [16]. 
Femoral block is one of the regional analgesic tech-
niques frequently applied by anesthesiologists when 
the lower extremities are involved [16–18].
The aim of this study was to evaluate the effect of 
femoral nerve block on the healing of experimental 
non-stabilized femur fractures via the assessment of 
the expression of TGF-b, VEGF, and b-catenin and 
bone histomorphometry in rat.
Material and methods
Experimental and animal design. All experiments were 
approved by the local Animal Ethics Committee at Marmara 
University School of Medicine, Istanbul, Turkey. To investi-
gate the effects of femoral nerve block on fracture healings 
in rat, a total of 72 male rats, each weighing between 120 and 
160 g, were divided randomly into three groups using 
sealed envelopes. In all groups, the animals were anes-
thetized by intramuscular injection of xylazine (50 mg/kg, 
Bayer United German Pharmaceutical Factories, Istanbul, 
Turkey) and ketamine hydrochloride (50 mg/kg, Parke-Davis, 
Istanbul, Turkey). 
Femoral fracture (ffx) technique. The femoral fractures 
were performed in line with the description of Le et al. [19]. 
After shaving the right leg, surgical fields were draped under 
sterile conditions. A vertical lateral incision at the femur was 
followed by muscular blunt dissection. The femur bone was 
fractured transversally with a manual bone cutter at the 
level of diaphysis. The bone was not fixated. The surgical 
wound was closed with a nonabsorbable suture. On Days 
4, 7, and 13, eight rats from each group were euthanized by 
decapitation. The right femurs were then excised.
Radiographic imaging. The rats were processed immediately 
after radiographic examination. Radiographic analysis was 
performed using a Siemens syngo fastView (2011, Siemens, 
Erlangen, Germany) while the rats were still under the effect of 
anesthetic drugs. The rats were placed first in the prone position 
and then in the lateral position. Their right legs were abducted. 
The X-ray images were taken at 45 kV, 2 mAS. The images were 
examined and the fractured bones were standardized (Figure 1).
Femoral nerve block (FNB) technique. Femoral nerve block 
(FNB) was carried out using the landmarking technique. For 
injection the rat was held in lateral recumbency with the limb 
to be injected forming a right angle with the longitudinal axis 
of the trunk. The greater trochanter and ischial tuberosity 
were localized by palpation. On an imaginary line from 
the greater trochanter to the ischial tuberosity, about one 
third of the distance caudal to the greater trochanter, the 
injection needle was advanced from dorsolateral direction at 
a 45° angel until the tip encountered the ischium [20]. 0.1 mL 
of 0.25% levobupivacaine (Chirocaine, Nycomed Pharma 
AS, Elverum, Norway) was injected. The success of FNB 
technique was tested through the withdrawal response of the 
paw to a forceps pinch on the lateral foot/toe. The pinch was 
limited to a maximum of 1 second. The sensory responses 
were evaluated on the basis of no response to pinch at full 
sensory block. Following experimental groups were set up:
—  Control group (n = 24): only ffx was performed; 
—  One-Day Block group (n = 24): after ffx was applied, 
FNB was performed for one day;
153The effect of femoral nerve block on femur fracture healing
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2016
10.5603/FHC.a2016.0017
www.fhc.viamedica.pl
—  Three-Days Block group (n = 24): after ffx was perfor-
med, FNB was applied as described above once a day 
for three consecutive days [17].
Additionally, 50 mg/kg ketorolac (Ketorolac trometamin, 
Deva, Istanbul, Turkey) was given to all rats intraperitoneally 
for postoperative analgesia for 5 days.
Histological analyses. Bone samples were fixed in 10% neu-
tral buffered formalin for 24 hours and then decalcified in 
decalcifier solution (Shandon TBD-2 Decalcifier, Runcorn, 
UK) at room temperature for 5 days. Each specimen was 
dehydrated using a graded ethanol series and later cleared 
in xylene, before being embedded in paraffin. The paraffin 
blocks were cut into 5 µm and the sections were mounted on 
glass slides. The sections were stained with hematoxylin acc. 
to Gill III and eosin (H&E staining) (Merck, Darmstadt, 
Germany) to evaluate bone morphology and Safranin O 
(Merck) to evaluate the presence of callus tissue and carti-
laginous and new bone areas. 
Histomorphometric analyses. Five serial sections from each 
leg and a minimum of five adjacent fields in each section 
were quantified at a magnification of ×40 objective lens. The 
thicknesses of the periosteum, number, thickness, and areas 
of trabeculae and cartilaginous new bone were evaluated 
histomorphometrically with a use of semiautomatic image 
analysis system (University of Texas Health Science Center 
at Santorino, TX, USA image tool for Windows version 
1.28 program) as described by other authors [6, 21–24]. All 
of the measurements were made in a blinded manner by 
a histologist.
Immunohistochemistry. Bone tissue sections 5-µm-thick 
were obtained from the paraffin blocks. The tissue blocks 
were chosen carefully after histological assessment of the 
sections stained with H&E. For immunohistochemical 
(IHC) staining, sections were incubated overnight at 60°C 
and then immersed in xylene and rehydrated in a decreasing 
series of ethanol solutions. The sections were washed with 
both distilled water and phosphate-buffered saline (PBS) 
solution (P4417; Sigma-Aldrich, St Louis, MO, USA) for 10 
min and then treated with citrate buffer (pH: 7.6) for 5 min 
in a pressure cooker. Following washing with PBS, the sec-
tions were delineated with a Dako Pap pen (Dako, Glostrup, 
Denmark) and incubated in a solution of 3% hydrogen 
peroxide (Peroxidase Block) for 5 min to inhibit endoge-
nous peroxidase activity. After washing in PBS, the sections 
were incubated with non-immune serum for 1 h and then 
incubated with primary antibodies: TGF-b (1:100, Genetex, 
Irvine, CA, USA), VEGF (1:100, cat no GTX22992, Gene-
tex), b-catenin (ready to use, cat no GTX15180, Genetex) 
overnight at 4°C in a humidity chamber. The sections were 
washed 3 times for 5 min each in PBS, followed by incuba-
tion with a post-primary rabbit anti-mouse IgG for 30 min 
and then with Novolink Polymer Anti-rabbit poly-HRP-IgG 
(Novocastra, RE715K, Newcastle, UK) for 30 min. After 
washing 3 times with PBS, the sections were incubated with 
DAB substrate buffer for 5 min using the NovoLink polymer 
detection system (RE715K, Novocastra). After washing 
with distilled water the sections were counterstained with 
Mayer’s hematoxylin and washed with distilled water. In the 
negative controls, the primary antibodies were omitted. All 
the sections were mounted with mounting medium (Shan-
don EZ-Mount, ThermoFisher Scientific, Waltham, MA, 
USA) and the immunoreactive cells were in Olympus BX51, 
bright-field microscope (Olympus, Tokyo, Japan). The 
presence of a brown precipitate indicated a positive reaction 
for primary antibodies. To determine the immunoreactivity 
of the sections, a series of semi-quantitative analyses were 
performed in the tissue materials. HSCORE was calculated 
using the following equation: HSCORE= ∑Pi (I + 1), where 
‘i’ is the intensity of labeling with a value of 1, 2 or 3 (weak, 
moderate, or strong, respectively) and Pi is the percentage 
of labelled cells for each intensity, varying from 0% to 100%.
Statistical analyses. For statistical analysis non-parametric 
ANOVA test, Kruskall Wallis test and Dunn’s test as a post-
hoc test were used (p < 0.05). For this analysis GraphPad 
Instat program (Graphpad Software Inc., La Jolla, CA, 
USA) was applied.
Figure 1. Radiographic image of nonstabilized femoral 
fracture of an anesthetized rat. The fracture was performed 
as described in Material and methods. Arrow shows site of 
fracture.
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Results
Effects of femoral fracture and femoral nerve block 
on the histomorphometric parameters of rat femur 
Periosteal thickness (Ps.Th): On Day 4, a significant 
increase was observed in the thickness of the perios-
teum of the One-Day block group and the Three-Day 
block group over that of the Control group (p < 0.05 
and p < 0.01 respectively) (Figure 2A, Table 1). 
Trabecular number (Tb.N): On Day 7, a signifi-
cant increase was seen in the trabecular numbers per 
area in the One-Day block group (p < 0.01) and the 
Three-Day block group (p < 0.05), as compared with 
the Control group. When we compared the Control 
group and the One-Day block group on Day 13, we 
found a significant increase in the One-Day block 
group (p < 0.001). It was also observed that there was 
a decrease in trabecular numbers between the One-
Day block and Three-day block groups (p < 0.001) 
(Figure 2B, Table 1).
Trabecular thickness (Tb.Wi): We could not find 
any statistical differences in the trabecular thickness 
between the groups (p > 0.05) (Figure 2B, Table 1).
Trabecular area (Tb.Ar): When we compared the 
One-Day Block with the Control group, we found an 
increase in the trabecular area, but this increase was 
not statistically significant by Day 7 (p > 0.05). There 
were statistically significant increases in the Three-
Day block group compared with the Control group 
(p < 0.001), and it was also observed that there was 
an increase in the trabecular area compared with the 
One-Day block group on Day 7 (p < 0.05). There was 
Table 1. Histomorphometric analyses of fractured and healing femoral bone in rats subjected to femoral nerve blockade 
on days 4, 7 and 13 after fracture
Day 4 Day 7 Day 13
Control  
group 
(n = 8)
1-Day  
group 
(n = 8)
3-Day  
group 
(n = 8)
Control  
group 
(n = 8)
1-Day  
group 
(n = 8)
3-Day  
group 
(n = 8)
Control  
group 
(n = 8)
1-Day  
group 
(n = 8)
3-Day  
group 
(n = 8)
Periosteum  
thickness 
34 ± 8 54 ± 13* 60 ± 13**
Trabecular  
number
16 ± 5 50 ± 14** 45 ± 31* 19 ± 5 34 ± 4*** 24 ± 4aaa
Trabecular  
thickness
16 ± 4 17 ± 4 18 ± 4 13 ± 3 16 ± 3 16 ± 3
Trabecular  
area
1120 ± 220 1356 ± 260 1766 ± 350***, a 782 ± 150 1259 ± 240*** 1335 ± 265***
Cartilaginous  
area
21 134 ± 2825 16 734 ± 1006*** 16 123 ± 1209*** 91 885 ± 1393 96 164 ± 
1627***
77 047 ±  
1400***, aaa
New bone  
area
68 899 ± 3809 10 4910 ± 4209* 84 145 ± 4530*** 136 192 ± 2013 131 705 ± 4803 189 980 ± 4347
Data present mean ± SD, n = 24. *, **, ***p < 0.05, p < 0.01, and p < 0.001, respectively, when compared with the same day Control group;  
a, aaap < 0.05 and p < 0.001 for the same day values between the One-Day and Three-Day Block groups. All thickness values are expressed in pixels 
(1 pixel = 0.36 µm) and all area values in pixel2.
Figure 2. The histological appearance of fracture area after femoral block application. A. One-Day Block group: *perio-
steum, H&E staining, ×40; B. One-Day Block group: **compact and trabecular bone, H&E staining, ×40; C. Three-Day 
Block group: +cancellous bone, ++new bone formation, safranin O staining, ×40.
A B C
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a significant increase in the One-Day and Three-Day 
block groups, as compared with the Control group on 
Day 13 (p < 0.001) (Figure 2B, Table 1).
Cartilaginous Area (Cg.Ar): There was a decrease 
in both the treatment groups on Day 7 compared with 
the Control group (p < 0.001). When we compared 
the One-Day block group with the Control group, 
an increase was found in the One-Day Block group 
(p < 0.001) and a decrease was found in the Three-
-Day Block group on Day 13 (p < 0.001). The carti-
laginous areas had decreased in the Three-Day block 
group, as compared with the One-Day block group on 
Day 13 (p < 0.001) (Figure 2C, Table 1).
New bone area (B.Ar): The statistical analysis 
showed that the new bone area increased in both block 
groups on Day 7 (p < 0.001); in addition, the One-Day 
block group’s new bone area decreased compared 
with the Control group, but this decrease was not 
statistically significant on Day 13 (p > 0.005). The 
Three-Day block group’s new bone area increased 
compared with the Control group and also increased 
compared with the One-Day block group on Day 13 
(p < 0.001) (Figure 2C, Table 1).
Effects of ffx and femoral nerve block on  
the immunoexpression of TGF-b, VEGF,  
and b-catenin in rat femur 
The H-SCORE values of TGF-b, VEGF, and 
b-catenin immunoreactivity in fracture healing were 
analyzed (Figure 3A–C). 
When compared with the control group, TGF-b 
expression was found to be statistically higher both 
in the One-Day block group and in the Three-Day 
block group at all times (p < 0.001 for all) (Figure 3A, 
Figure 4A1–A3). 
When compared with the control group, there were 
significant increases in VEGF expressions in both 
groups at all times (p < 0.001 for all). There was no 
significant difference between the VEGF expression 
in the block groups on Day 4 or Day 13 (Figure 3B, 
Figure 4B1–B3). 
There were increases on Day 7 in the b-catenin ex-
pression of the One-Day and of the Three-Day block 
groups over the Control group. However, there was 
a significant increase in the Three-Day block group 
on Day 13 (p < 0.05). b-catenin expression was the 
same for the two block groups on Day 7, but in the 
Figure 3. Comparison of the immunohistochemical expression of growth factors and b-catenin. Expression of TGF (A), 
VEGF (B) and b-catenin (C) in Control, One-Day Block and Three-Day Block Groups. *, **, ***compared with Control group 
on the same day, p < 0.05, p < 0.01 and p < 0.001, respectively; acompared with the other groups on the same day, p < 0.05.
A B
C
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Three-Day block group, the expression had increased 
by Day 13 (Figure 3C, Figure 4C1–C3).
Discussion
By Day 3 after a fracture, when the fracture formation 
healing process starts, MSCs are recruited and begin to 
proliferate. They subsequently differentiate into chon-
droblasts. The proliferation of these new chondrocytes 
occurs from Day 7 to Day 21, resulting in formation of 
the soft callus. The periosteum is the most important 
factor at this stage. When the periosteum is removed, 
the fracture callus development is diminished, because 
better periosteal growth may lead to better endochon-
dral ossification [1, 25]. In our study, we showed that 
the periosteum thicknesses of the treatment groups 
were higher than those of the Control group on Day 4. 
Le et al. have shown that fracture healing in both 
nonimmobilized and immobilized rat fracture calluses, 
though different radiographically and histologically, 
is characterized by similar biochemical changes in the 
ground substance [19]. Although the callus that forms 
in the immobilized model is appreciably smaller than 
that formed when the fracture is not immobilized, the 
chemical composition of the organic matrix of the ex-
isting callus undergoes similar modifications, regardless 
of fixation or histological response.
After Day 7, the cartilaginous callus surrounding 
the fracture site has become large [1, 3, 19]. Vort-
kamp et al. claim that, by Day 14, the callus has 
been replaced by bone in the fracture area, so that 
only small cartilage regions remain [26]. Diniz et al. 
suggest that the persistence of a large cartilaginous 
callus, together with a trabecular bone with sparse 
spacing, imply delayed healing and less mature cal-
luses in rodents [27]. In our study, the reduction of 
the cartilaginous area, and the increase in the new 
bone and trabecular area and number were identi-
fied; these positive effects depend on femoral block 
treatment after the fracture.
Previous studies show that TGF-b a potent mitogen 
for bone-forming cells that controls the proliferation 
of undifferentiated mesenchymal and osteoprogenitor 
cells, osteoblasts, and chondrocytes — is expressed 
from an early stage in fracture healing. TGF-b is 
secreted in the fracture site on Day 0 and secretion 
continues to Day 21 of the healing process. By Day 3, 
MSC proliferation and angiogenesis have begun as 
a result of TGF-b expression. By Day 7, after fracture 
endochondral ossification has started, TGF-b expres-
sion continues. By Day 14, TGF-b expression is declin-
ing [1, 3, 28]. Our results show that TGF-b expression 
in the femoral nerve block groups was found to be 
higher than in the Control group on Days 4, 7, and 13.
Figure 4. Immunohistochemical expression of TGF-b, VEGF and b-catenin around the trabeculae in the fracture area. 
A1–3. TGF-b expression on Day 13 in Control, One-Day and Three-Day block groups, respectively; B1–3. VEGF expres-
sion on Day 13 in Control, One-Day and Three-Day block groups, respectively; C1–3. b-catenin expression on Day 13 in 
Control, One-Day and Three-Day block groups, respectively. Arrow shows osteoblast, magnification ×400.
A1 A2 A3
B1 B2 B3
C1 C2 C3
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The literature reveals that VEGF has been shown 
to stimulate bone healing in the fracture callus 
during repair in animal models [5, 28]. Kanczler et 
al. indicate that VEGF factor isoforms are essential 
in coordinating cartilage formation and ossification 
during endochondral bone development [29]. The 
stimulation of the circulation of endosteum — 
a membrane lining the inner surface of the bone — 
allows the MSCs associated with growing capillaries 
to invade the wound region from the endosteum 
and bone marrow. VEGF expression is detected in 
chondroblasts, chondrocytes, osteoprogenitor cells, 
and osteoblasts in the fracture callus, where it is 
highly expressed in angioblasts, osteoprogenitor, and 
osteoblast cells during the first seven days of healing, 
but decreases after eleven days, activating not only 
angiogenesis but also osteoclast recovery, differen-
tiation, and activity. This leads to the remodeling of 
the fracture callus during endochondral ossification. 
Other studies indicate that VEGF expression starts 
on Day 14 after the fracture, and goes on throughout 
the remodeling process. Investigations of the tissue 
level report increased interaction between blood 
vessel formation and bone regeneration [1, 3, 6]. 
Kanczler et al. claim that the inhibition of VEGF in 
fractured mouse femurs results in a decrease in blood 
vessel invasion with a reduction in osteoclastic bone 
remodeling, impaired callus mineralization, and re-
duced trabecular bone healing [29]. Our study shows 
that the VEGF expression of the treatment groups 
increases after the application of femoral nerve block. 
b-catenin has a major effect on the differentia-
tion of MSCs to osteoblasts and chondroblasts in 
bone fracture healing. Studies have shown that the 
activation of b-catenin increases in the early period 
of endochondral ossification but decreases in its late 
period. When an osteoblast changes into an osteocyte, 
b-catenin expression decreases in the late period of 
differentiation. The expression of b-catenin increases 
on Day 3 and rises to a peak on Day 10, but cannot be 
detected in rats on Day 21 [15, 30]. Our results suggest 
that the application of femoral nerve block for three 
days resulted in greater expression of b-catenin on 
Day 13 in the group that received it than in the others.
This study has revealed that, in the case of femoral 
fracture, the application of femoral nerve block accel-
erates the healing process of femoral fracture in rats. 
In addition to the humanitarian and economic as-
pects of effective pain management, the use of nerve 
block provides better postoperative pain control than 
systemic patient-controlled analgesia (PCA) [31, 32], 
reduces the need for opioids and their related com-
plications, allows earlier mobilization and functional 
recovery, and shortens stays at hospitals and reha-
bilitation centers [33, 34]. Most studies agree that 
opioid consumption decreases by 40–70% when 
nerve blocks are used, when compared with PCA 
alone. Another significant advantage of the use of 
nerve blocks in the ambulatory patient is that this 
technique decreases the frequency of unanticipated 
admissions and readmissions after same-day surgery, 
together with their associated costs [33]. It has also 
been shown that the administration of nonsteroidal 
anti-inflammatory agents, such as tenoxicam [35] and 
diclofenac [29], and of opioids like morphine [36] 
leads to delay in the fracture healing process. 
However, the application of femoral block, leads to 
a decrease in the use of nonsteroidal anti-inflam-
matory agent and opioids for pain management at 
the perioperative period, and is beneficial from the 
fracture healing perspective.
In light of this study, we can postulate that, in the 
case of femoral fracture, the application of femoral 
nerve block, either once only or once a day for three 
consecutive days, had a positive impact via growth 
factors and WNT/b-catenin signaling pathway acti-
vation, and histomorphometrically results in early 
fracture healing. Moreover, these effects accelerate 
the healing process of femoral fracture in rats.
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